The HTA secretariat shall ensure that all the information received from the health technology developer, the European Medicines Agency, patients, clinical experts and other relevant experts and Member States related to joint clinical assessments and updates of joint clinical assessments is communicated to the Coordination Group, to its relevant subgroups and/or to the assessor and co-assessor, as appropriate, upon receipt of that information.
Art. 4 Regulation (EU) 2024/1381
Information to the Coordination Group
In forcesince 23 May 2024